Disc Medicine (IRON) Accumulated Expenses (2020 - 2026)

Disc Medicine (IRON) has reported Accumulated Expenses for 7 consecutive years, with $8.9 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Accumulated Expenses rose 44.15% year-over-year to $8.9 million; the TTM figure through Jun 2026 stood at $8.9 million (up 44.15% YoY), while the FY2025 annual figure was $15.6 million, up 92.18% from the prior year.
• Accumulated Expenses advanced to $8.9 million in Q2 2026 per IRON's latest filing, from $6.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $15.6 million in Q4 2025 and bottomed at $325000.0 in Q3 2022.
• Historically, Accumulated Expenses has averaged $6.2 million across 5 years, with a median of $5.8 million in 2022.
• Annual changes were most pronounced in 2022 — Accumulated Expenses slumped 95.17% — and 2023, when it jumped 1612.92%.
• Disc Medicine's Accumulated Expenses stood at $6.1 million in 2022, then rose by 0.82% to $6.2 million in 2023, then surged by 31.47% to $8.1 million in 2024, then surged by 92.18% to $15.6 million in 2025, then plunged by 42.93% to $8.9 million in 2026.
• Business Quant data shows IRON's Accumulated Expenses at $8.9 million in Q2 2026, $6.8 million in Q1 2026, and $15.6 million in Q4 2025.